ARDELYX INC (ARDX)

US0396971071 - Common Stock

6.48  +0.04 (+0.62%)

Premarket: 6.64 +0.16 (+2.47%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ARDELYX INC

NASDAQ:ARDX (4/19/2024, 7:00:00 PM)

Premarket: 6.64 +0.16 (+2.47%)

6.48

+0.04 (+0.62%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap1.51B
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ARDX Daily chart

Company Profile

Ardelyx, Inc. is a biopharmaceutical company. The company is headquartered in Fremont, California and currently employs 133 full-time employees. The company went IPO on 2014-06-19. The firm focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. The firm's product pipeline includes IBSRELA (tenapanor), XPHOZAH, RDX013 Program, and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of or the control of hyperphosphatemia or serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). XPHOZAH is a medicine for the control of serum phosphorus in adult patients with CKD on dialysis. RDX013 Program is a small molecule potassium secretagogue program for the treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis.

Company Info

ARDELYX INC

34175 Ardenwood Blvd

Fremont CALIFORNIA 94555

P: 15107457047

CEO: Michael Raab

Employees: 133

Website: https://www.ardelyx.com/

ARDX News

News Image4 days ago - Ardelyx, Inc.Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

Conference call scheduled for 4:30 p.m. Eastern Time

News Image10 days ago - Market News VideoFirst Week of May 31st Options Trading For Ardelyx (ARDX)
News Image25 days ago - Market News VideoArdelyx Enters Oversold Territory (ARDX)
News Image25 days ago - Ardelyx, Inc.Ardelyx, Inc. Reports Employment Inducement Grants
News Image25 days ago - Ardelyx, Inc.Ardelyx, Inc. Reports Employment Inducement Grants

WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...

News Image25 days ago - Market News VideoARDX May 10th Options Begin Trading

ARDX Twits

Here you can normally see the latest stock twits on ARDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example